Immunocytochemical detection of phosphatidylinositol 3 kinase in Burkitt lymphoma cells

被引:1
|
作者
Miscia, S
di Baldassarre, A
Rana, RA
Pucci, AM
Cataldi, A
机构
[1] Univ G DAnnunzio, Inst Morfol Umana Normale, I-66100 Chieti, Italy
[2] Univ Parma, Ist Anat Umana Normale, I-43100 Parma, Italy
关键词
PI; 3-kinase; interferon; Burkitt lymphoma cells;
D O I
10.1247/csf.23.17
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PI 3-kinase, an enzyme responsible for the phosphorylation of the D3 position of the inositol ring of phosphatidylinositol (PI), is recognized to be involved in the regulation of many cellular processes such as mitogenic signalling, inhibition of apoptosis, intracellular vesicle trafficking/secretion, regulation of actin and integrin functions and regulation of protein kinases induced by tumour necrosis factor, oncoproteins and ultraviolet light. Here we report the subcellular distribution and the phosphorylative pattern of p85 alpha subunit of PI 3-kinase in Burkitt lymphoma cells exposed to R interferon alpha treatment. Immunocytochemical analysis of this enzyme, performed by confocal microscopy, revealed an increased expression of this protein at cytoplasmic level after 90 min of interferon a treatment. Western blotting analyses performed on nuclear and cytoplasmic fractions confirmed the overexpression found by confocal microscopy at cytoplasmic level in the 90 min interferon alpha treated cells still persisting in the 24 hr treated samples. Such an overexpression was paralleled by an increase of tyrosine phosphorylation both at cytoplasmic and nuclear level suggesting that an enhanced requirement for cytoplasmic expression and phosphorylation of PI 3-kinase might be necessary to the cell for regulating some cytoplasmic-nuclear cross talk involved in the control of Burkitt lymphoma cell metabolism following interferon alpha treatment.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [21] Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
    Fang X.
    Zhou X.
    Wang X.
    Biomarker Research, 1 (1)
  • [22] DIFFERENTIATION OF BURKITT-LYMPHOMA CELLS BY HEXAMETHYLENBISACETAMIDE
    SEMMEL, M
    HANANIA, N
    HUET, S
    PAVLOFF, N
    GAY, F
    BIQUARD, JM
    MOLECULAR BIOLOGY REPORTS, 1989, 13 (03) : 151 - 157
  • [23] EXPRESSION OF ADENOVIRUS IN BURKITT-LYMPHOMA CELLS
    FAUCON, N
    CHARDONNET, Y
    ANNALES D IMMUNOLOGIE, 1977, C128 (4-5): : 957 - 958
  • [24] CLONING OF BURKITT LYMPHOMA CELLS CULTURED IN VITRO
    HINUMA, Y
    GRACE, JT
    CANCER, 1968, 22 (06) : 1089 - &
  • [25] EFFECT OF CENTRIFUGATION ON VIABILITY OF BURKITT LYMPHOMA CELLS
    WANG, DIC
    SINSKEY, TJ
    GERNER, RE
    DEFILIPP.RP
    BIOTECHNOLOGY AND BIOENGINEERING, 1968, 10 (05) : 641 - &
  • [26] STUDIES OF BURKITT LYMPHOMA CELLS .3. EQUILIBRIUM DENSITY GRADIENT CENTRIFUGATION OF VIRUS PARTICLES ISOLATED FROM BURKITT LYMPHOMA CELL LINES
    MINOWADA, J
    CHAI, L
    MOORE, GE
    CANCER, 1969, 23 (02) : 300 - +
  • [27] Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
    Slupianek, A
    Nieborowska-Skorska, M
    Hoser, G
    Morrione, A
    Majewski, M
    Xue, LQ
    Morris, SW
    Wasik, MA
    Skorski, T
    CANCER RESEARCH, 2001, 61 (05) : 2194 - 2199
  • [28] FROM BURKITT-LYMPHOMA TO BURKITT CELLS - CLINICAL, IMMUNOLOGICAL AND GENETIC DATA
    SCHAISON, G
    BERGER, R
    PREUDHOMME, JL
    FLANDRIN, G
    BOIRON, M
    SEMAINE DES HOPITAUX, 1983, 59 (07): : 496 - 497
  • [29] NOVEL FUNCTIONS OF PHOSPHATIDYLINOSITOL 3-KINASE IN TERMINALLY DIFFERENTIATED CELLS
    NAKANISHI, S
    YANO, H
    MATSUDA, Y
    CELLULAR SIGNALLING, 1995, 7 (06) : 545 - 557
  • [30] Inhibition of Phosphatidylinositol-3-Kinase by Hibiscone C in T cells
    Rawlings, Jason S.
    Besley, Caroline
    Goess, Brian
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):